Huadong Pharmaceutical (Xi'an) Bohua Pharmaceutical Co., Ltd., founded in September 1998, is now a wholly-owned subsidiary of the Listed Company Hangzhou Zhongmei Huadong. With a registered capital of 80 million yuan and total assets of 160 million yuan, the company covers an area of more than 125 Mu and a plant of more than 10000 square meters. At present, the company has 44 approval numbers, including 38 preparations and 6 raw materials. Its products involve anti infective drugs, cardiovascular and cerebrovascular drugs, digestive system drugs, antipyretic and analgesic drugs, psychiatric system drugs and so on. The main preparation varieties include ornidazole tablets, suppository (Xiaoran), omeprazole enteric coated capsules, Domperidone Tablets, Cefetamet Pivoxil hydrochloride tablets (bosuli), acetic hydroxylamine acid capsules (junshitong), hydroxyaluminum tablets (Xiyueweikang), methylnicotinamide tablets (Gandan), migraine tablets, aspirin enteric coated tablets, etc; The main APIs include indobufen, ornidazole, chlorhexidine acetate, chlorhexidine hydrochloride, silkworm pupa powder, etc.

The company has nearly 300 employees, including more than 150 professional and technical talents. The company has established a new product R & D center with strong development and application strength of new products, new technologies and new processes. The company obtained the high-tech enterprise certificate in 2003 and 2020 respectively. The company has 22 core patents, obtained the supplementary application approval for Domperidone Tablets consistency evaluation in May 2020, and entered the third batch of national centralized drug procurement in August of the same year. The winning areas include Beijing, Anhui, Fujian, Hebei, Henan, Jiangxi, Qinghai, Shandong, Shaanxi, Inner Mongolia Autonomous Region and Xinjiang Uygur Autonomous Region, There are 11 regions in total. The company has a perfect marketing system and a marketing network covering more than 20 provinces and cities in China.

The company controls Shaanxi Jiuzhou Pharmaceutical Co., Ltd., creating a broader business platform for the company's sustained and rapid development.

The company adheres to the enterprise philosophy of being cautious, being honest and responsible, the core values of overall supremacy, and the enterprise spirit of loyalty, simplicity, diligence and innovation; Strengthen the corporate mission of creating value for customers, creating benefits for shareholders, creating opportunities for employees and taking responsibility for society; Strive to realize the corporate vision of being a sincere man, being a refined medicine and benefiting mankind.